VR Logo

Aptose Biosciences Inc. (APTO) download report


Healthcare | Biotechnology & Pharma Research

Aptose Biosciences Inc. (APTO) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States.

IPO Date: 23-Oct-2014

Chairman, Pres, CEO & Chief Accounting Officer: Dr. William G. Rice Ph.D.

Sr. VP & Chief Medical Officer: Dr. Rafael Bejar M.D., Ph.D.

Listing: NASDAQ: APTO

Country: Canada

Headquarters: Toronto, ON

Website: https://www.aptose.com

Key Facts

Market cap: $76.26 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-60.61 Mln

Cash: $69.51 Mln

Total Debt: $0.53 Mln

Insider's Holding: 5.37%

Liquidity: Low

52 Week range: $0.75 - 3.43

Shares outstanding: 92,229,200

10 Years Aggregate:

  • CFO: $-176.32 Mln
  • EBITDA: $-161.11 Mln
  • Net Profit: $-238.38 Mln

Stock Performance

Time Period Aptose Biosciences (APTO) S&P BSE Sensex* S&P Small-Cap 600*
YTD-41.68-8.97-18.40
1 month-17.13-3.38-8.42
3 months-34.39-7.93-14.06
1 Year-76.840.55-17.64
3 Years-30.8410.416.75
5 Years-6.4711.456.18
10 Years-17.7012.0510.23
As on 28-Jun-2022 *As on 29-Jun-2022
Year Aptose Biosciences (APTO) S&P Small-Cap 600 S&P BSE Sensex
2021-69.1825.2721.99
2020-22.759.5715.75
2019196.8620.8614.38
2018-14.66-9.705.87
201761.1511.7327.91
2016-45.0624.741.95
2015-57.48-3.36-5.03